LISATA THERAPEUTICS, INC. Shareholders' Equity
LISATA THERAPEUTICS, INC. (LSTA) had Shareholders' Equity of $8.24 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $8.24M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.93M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $14.86M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $17.37M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $8.24M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $10.93M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $14.86M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $17.37M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $21.03M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $25.36M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $29.57M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $33.69M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $38.25M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $43.00M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $48.15M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $52.96M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $57.97M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $60.96M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $66.58M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $72.03M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $82.39M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $88.50M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $92.25M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $98.67M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $104.93M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $110.27M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $32.50M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $37.74M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $33.81M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $17.24M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $20.82M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $25.25M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $29.89M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $34.73M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $37.73M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $41.08M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $43.74M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $45.59M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $50.51M 10-K · filed 2019-03-14 | $50.51M 10-K · filed 2018-03-22 |
| 2017-09-30 | $53.33M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $54.42M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | -$790.97K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.88M 10-K · filed 2018-03-22 | |
| 2016-09-30 | $10.75M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $6.05M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $13.66M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $23.71M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $55.43M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $66.38M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $50.40M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $58.51M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $63.00M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $78.04M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $59.64M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $62.54M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $35.70M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $33.46M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $29.42M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $33.18M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $48.21M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $46.35M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $63.37M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $62.03M 10-K · filed 2013-03-11 | |
| 2011-09-30 | $73.56M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $62.51M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $48.66M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |